trial · primary record
CAR-T cells
Multiple Myeloma
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 20 |
| Primary completion | 2028-12-31 |
| Primary endpoint | Percentage of patients with treatment related adverse effects |
| Registry ID | NCT06429150 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:45:20.613Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06429150
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.